Detalhe da pesquisa
1.
AT-RvD1 Mitigates Secondhand Smoke-Exacerbated Pulmonary Inflammation and Restores Secondhand Smoke-Suppressed Antibacterial Immunity.
J Immunol
; 206(6): 1348-1360, 2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33558371
2.
Specialized Proresolving Mediators Overcome Immune Suppression Induced by Exposure to Secondhand Smoke.
J Immunol
; 205(11): 3205-3217, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33115852
3.
Importance of myeloid derived suppressor cells in cancer from a biomarker perspective.
Cell Immunol
; 361: 104280, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33445053
4.
Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections.
J Immunol
; 200(8): 2927-2940, 2018 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29555783
5.
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy.
Cancer Immunol Immunother
; 65(7): 813-9, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26910314
6.
T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med
; 190(1): 40-50, 2014 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24825462
7.
Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.
Cells
; 10(6)2021 05 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34071188
8.
Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients.
Oncoimmunology
; 9(1): 1824863, 2020 09 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33101775
9.
Augmentation of IFN-γ+ CD8+ T cell responses correlates with survival of HCC patients on sorafenib therapy.
JCI Insight
; 4(15)2019 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31391334
10.
Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib.
Oncoimmunology
; 5(10): e1226718, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27853648
11.
PD-1+ and Foxp3+ T cell reduction correlates with survival of HCC patients after sorafenib therapy.
JCI Insight
; 1(11)2016 Jul 21.
Artigo
Inglês
| MEDLINE | ID: mdl-27540594
12.
Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease.
Ann Am Thorac Soc
; 12 Suppl 2: S169-75, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26595735